# A Clinical Study on the Efficacy and Safety of the Treatment of Hyperplasia of Mammary Glands With Xiaoru Sanjie Capsule

> **NCT02929420** · PHASE4 · UNKNOWN · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 600 (estimated)

## Conditions studied

- Fibrocystic Disease of Breast

## Interventions

- **DRUG:** Xiaoru Sanjie capsules
- **DRUG:** Xiao Yao pills

## Key facts

- **NCT ID:** NCT02929420
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2016-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02929420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02929420, "A Clinical Study on the Efficacy and Safety of the Treatment of Hyperplasia of Mammary Glands With Xiaoru Sanjie Capsule". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02929420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*